搜龙体育

 
邱录贵课题组与常洪课题组合作在Clinical Cancer Research期刊发表文章

  我所邱录贵课题组与常洪课题组合作在Clinical Cancer Research期刊发表文章“ miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma ”。

Abstract

  

PURPOSE:

  Deregulation of miRNA has been implicated in the pathogenesis of multiple myeloma. We identified miR-137 and miR-197, mapped to the chromosome 1p (12)-(21) deletion region, and examined their antimyeloma activity as tumor suppressors.

EXPERIMENTAL DESIGN:

  The expression of miR-137/197 was examined in multiple myeloma and normal plasma cells by qRT-PCR. Functional effect of miR-137/197 was analyzed by cell viability, apoptosis, clonogenic, and migration assays. Antimyeloma activity of miR-137/197 was further evaluated in vivo by lentiviral-based or lipid-based delivery in a mouse xenograft model of multiple myeloma.

RESULTS:

  miR-137/197 expression was significantly lower in multiple myeloma cell lines and multiple myeloma patient samples compared with normal plasma cells. Transfection of miR-137/197 resulted in reduction of MCL-1 protein expression, as well as alteration of apoptosis-related genes, and induction of apoptosis, inhibition of viability, colony formation, and migration in multiple myeloma cells. MCL-1 was further validated as a direct target of miR-137/197. Conversely, overexpression of MCL-1 partially reverted the effect of miR-137/197. Importantly, in vivo lentiviral-mediated or intratumor delivery of miR-137/197 induced regression of tumors in murine xenograft models of multiple myeloma.

CONCLUSIONS:

  Our study reveals a novel role of miR-137/197 as tumor suppressors in mediating apoptosis in multiple myeloma cells by targeting MCL-1. Our findings provide a proof-of-principle that lentivirus-based or formulated synthetic miR-137/197 exerts therapeutic activity in preclinical models, and support a framework for development of miR-137/197-based treatment strategies in patients with multiple myeloma.

  ©2015 American Association for Cancer Research.

   
搜龙体育导航 | 联系搜龙体育 | 使用帮助 | 搜龙体育声明


搜龙体育 picaotop.com:中国医学科搜龙体育血液学研究所血液病医院  技术支持:北方网
  备案序号:
建议使用IE6.0以上浏览器,分辨率1024*768

ku���ֹٷ���վ_ku���������34ƽ̨_��34���������ֹ���app���ؿͻ���_���ֹ���app��������_���ֹ���app�����Ϻ���3����long8��8�����ͻ��� ssboxin.com shandongguakao.com 168work.com longyanair.com kamatani-zei.com fgxkw.com 南方双彩乐彩网正版ub8账号注册南方双彩网中国体育彩票竞彩官网彩票365手机版南方双彩网乐橙竞彩下载南方双彩网南方彩票app风速体育直播彩票365手机版